197 related articles for article (PubMed ID: 27775051)
1. Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.
Sun J; Sun J; Song B; Zhang L; Shao Q; Liu Y; Yuan D; Zhang Y; Qu X
Sci Rep; 2016 Oct; 6():35855. PubMed ID: 27775051
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol suppresses expression of the regulatory T-cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor-κB activation.
Osabe M; Tajika T; Tohkin M
J Appl Toxicol; 2018 Feb; 38(2):274-283. PubMed ID: 28949055
[TBL] [Abstract][Full Text] [Related]
3. Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages.
Lin YC; Huang MY; Lee MS; Hsieh CC; Kuo HF; Kuo CH; Hung CH
J Microbiol Immunol Infect; 2018 Feb; 51(1):18-26. PubMed ID: 27325144
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor activity of fucoidan is mediated by nitric oxide released from macrophages.
Takeda K; Tomimori K; Kimura R; Ishikawa C; Nowling TK; Mori N
Int J Oncol; 2012 Jan; 40(1):251-60. PubMed ID: 21874230
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis.
Maolake A; Izumi K; Shigehara K; Natsagdorj A; Iwamoto H; Kadomoto S; Takezawa Y; Machioka K; Narimoto K; Namiki M; Lin WJ; Wufuer G; Mizokami A
Oncotarget; 2017 Feb; 8(6):9739-9751. PubMed ID: 28039457
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
[TBL] [Abstract][Full Text] [Related]
7. (+)-Nootkatone inhibits tumor necrosis factor α/interferon γ-induced production of chemokines in HaCaT cells.
Choi HJ; Lee JH; Jung YS
Biochem Biophys Res Commun; 2014 May; 447(2):278-84. PubMed ID: 24704449
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.
Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW
Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403
[TBL] [Abstract][Full Text] [Related]
9. Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA.
Kim J; Pena JV; McQueen HP; Kong L; Michael D; Lomashvili EM; Cook PR
Cancer Gene Ther; 2024 Jan; 31(1):28-42. PubMed ID: 37990062
[TBL] [Abstract][Full Text] [Related]
10. Macrophage CCL22 expression in the tumor microenvironment and implications for survival in patients with squamous cell carcinoma of the tongue.
Kimura S; Nanbu U; Noguchi H; Harada Y; Kumamoto K; Sasaguri Y; Nakayama T
J Oral Pathol Med; 2019 Sep; 48(8):677-685. PubMed ID: 31134686
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan induces nitric oxide production via p38 mitogen-activated protein kinase and NF-kappaB-dependent signaling pathways through macrophage scavenger receptors.
Nakamura T; Suzuki H; Wada Y; Kodama T; Doi T
Biochem Biophys Res Commun; 2006 Apr; 343(1):286-94. PubMed ID: 16540084
[TBL] [Abstract][Full Text] [Related]
12. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages.
Li XN; Su J; Zhao L; Xiang JB; Wang W; Liu F; Li HY; Zhong JT; Bai X; Sun LK
Int Immunopharmacol; 2013 Nov; 17(3):785-92. PubMed ID: 24070708
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species are involved in the IFN-γ-stimulated production of Th2 chemokines in HaCaT keratinocytes.
Qi XF; Teng YC; Yoon YS; Kim DH; Cai DQ; Lee KJ
J Cell Physiol; 2011 Jan; 226(1):58-65. PubMed ID: 20625996
[TBL] [Abstract][Full Text] [Related]
14. Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.
Anz D; Rapp M; Eiber S; Koelzer VH; Thaler R; Haubner S; Knott M; Nagel S; Golic M; Wiedemann GM; Bauernfeind F; Wurzenberger C; Hornung V; Scholz C; Mayr D; Rothenfusser S; Endres S; Bourquin C
Cancer Res; 2015 Nov; 75(21):4483-93. PubMed ID: 26432403
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan reduced the invasion of oral squamous cell carcinoma cells and modified their effects to macrophages.
Lin J; Wang K; Wang H; Shao Q; Luan Y; Xu Y; Song X; Tan W; Liu S; Wei F; Qu X
Med Oncol; 2017 Jan; 34(1):9. PubMed ID: 28004293
[TBL] [Abstract][Full Text] [Related]
16. Isobutyrylshikonin inhibits lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in BV2 microglial cells by suppressing the PI3K/Akt-mediated nuclear transcription factor-κB pathway.
Jayasooriya RG; Lee KT; Kang CH; Dilshara MG; Lee HJ; Choi YH; Choi IW; Kim GY
Nutr Res; 2014 Dec; 34(12):1111-9. PubMed ID: 25454762
[TBL] [Abstract][Full Text] [Related]
17. AKT signaling is involved in fucoidan-induced inhibition of growth and migration of human bladder cancer cells.
Cho TM; Kim WJ; Moon SK
Food Chem Toxicol; 2014 Feb; 64():344-52. PubMed ID: 24333868
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effects of the acid polysaccharide fraction from one of anamorph of Cordyceps sinensis on Ana-1 cells.
Chen W; Yuan F; Wang K; Song D; Zhang W
J Ethnopharmacol; 2012 Aug; 142(3):739-45. PubMed ID: 22710292
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.
Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Hidaka T; Aiba S
Anticancer Res; 2017 Jul; 37(7):3461-3471. PubMed ID: 28668835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
